跳至主要内容
临床试验/JPRN-UMIN000043475
JPRN-UMIN000043475已完成未知

Effect of enterally administered sleep-promoting medication on the intravenous sedative dose and its safety and cost profile in mechanically ventilated patients: a retrospective cohort study - Effect of enterally administered sleep-promoting medication on the intravenous sedative dose and its safety and cost profile in mechanically ventilated patients: a retrospective cohort study

Department of Emergency and Critical Care Medicine, Hyogo Prefectural Amagasaki General Medical Center0 个研究点目标入组 123 人开始时间: 2021年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
123

研究概览

简要总结

The average daily propofol dose per body weight administered as a continuous sedative during mechanical ventilation through an oral endotracheal tube was significantly lower in the early administration group (EA group) than in the late administration (LA group) and no administration group (NA group) (Beta Coefficient -5.18 [95% CI -8.95 to -1.40], Beta Coefficient -4.51 [95% CI -8.58 to -0.44]); however, there was no difference between the LA and NA groups (Beta Coefficient 0.66 [95% CI -3.14 to 4.46]).

研究设计

研究类型
Observational

入排标准

年龄范围
15years-old 至 120years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • central nervous system disease (stroke, epilepsy, meningitis, encephalitis, etc.), cardiopulmonary arrest, traumatic brain injury, overdose, gastrointestinal tract impracticability (administration of continuous neuromuscular blockade, abdominal surgery, ileus, gastrointestinal bleeding, etc.), previous psychiatric or cognitive pathology, Child C hepatopathy, pregnancy, previous tracheostomy, ICU readmission, lacking body weight records, death in ICU, and not receiving propofol.

研究者

发起方
Department of Emergency and Critical Care Medicine, Hyogo Prefectural Amagasaki General Medical Center

相似试验